(Berlin) mivenion will be exhibitor at this year’s meeting of the American College of Rheumatology (ACR) in San Francisco.
The meeting will take place from November 6th to 11th at the Moscone Convention Center. We will introduce our newest Xiralite X5 system to the international public.

For the first time, mivenion will be visible in one the most interesting health care markets. With succesfull approval of our Xiralite Fluorescence Imaging System X4 by the FDA, mivenion is now presenting it’s innovative imaging technology to a larger professional audience. In addition, a prototype of our future premium product, Xiralite X5, is displayed.
Our first appearance with Xiralite in the US with introduction of our technology to a new market is supported by the European Union and the European Regional Development Fund.